| # | Drug | Count |
|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 6 |
| 1 | APIXABAN | 3 |
| 2 | METHOTREXATE | 3 |
| 3 | METHOTREXATE SODIUM | 3 |
| 4 | TADALAFIL | 3 |
| 5 | TREPROSTINIL | 3 |
| 6 | ABATACEPT | 2 |
| 7 | BOSENTAN | 2 |
| 8 | ETANERCEPT | 2 |
| 9 | FUROSEMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINUTUXIMAB | 1 | 0.0012 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 6 | 0.0007 |
| 2 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 4 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 5 | FONDAPARINUX SODIUM | 1 | 0.0001 |
| 6 | RASAGILINE MESYLATE | 1 | 0.0001 |
| 7 | ROPINIROLE | 1 | 0.0001 |
| 8 | PRAMIPEXOLE | 1 | 0.0001 |
| 9 | APIXABAN | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 2 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 1 | 0.0000 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Prostacycline Vasodilator [EPC] | 3 | 0.0000 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 2 | 0.0000 |
| 7 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Factor Xa Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |